dreamstime_xs_269220610
Photo 269220610 | Astrazeneca China © RobertWei | Dreamstime.com

With the US-China tariff war showing every sign of worsening, multinational firms are considering building independent supply chains for the US and China.

Leading pharmaceutical company AstraZeneca has announced plans to establish manufacturing plants in China to serve the region exclusively.

For China-focused forwarders, the news represents a beacon of hope that the logistics industry may be shielded from the worst of the tariff and tension fallout.

A spokesperson from Dimerco told The Loadstar the move by AstraZeneca demonstrated companies’ faith in China’s self-sufficient ...

Please Register

To continue reading, please login or register for full access to our free content
Loadstar subscriber
New Loadstar subscriber REGISTER

Comment on this article


You must be logged in to post a comment.